AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
68 hedge funds and large institutions have $41.2M invested in AVEO Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 25 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
44% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 25
79% less call options, than puts
Call options by funds: $6K | Put options by funds: $28K
Holders
68
Holding in Top 10
3
Calls
$6K
Puts
$28K
Top Buyers
| 1 | +$748K | |
| 2 | +$391K | |
| 3 | +$363K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$334K |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$302K |
Top Sellers
| 1 | -$2.51M | |
| 2 | -$1.83M | |
| 3 | -$1.6M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.37M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.06M |